| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.34B | -42.0% |
| Cost of Revenue | $1.45B | -39.2% |
| SG&A Expense | $1.14B | -35.3% |
| Operating Income | -$60.1M | +75.4% |
| Pre-tax Income | $1.84B | +149.4% |
| Income Tax | -$30.8M | -120.6% |
| Net Income | $1.59B | +139.2% |
| EPS (Basic) | $4.33 | +145.5% |
| EPS (Diluted) | $4.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.82B | +28.3% |
| Short-term Investments | $335.6M | -83.1% |
| Accounts Receivable | $449.8M | -48.3% |
| Current Assets | $3.30B | -41.5% |
| Total Assets | $25.44B | -39.6% |
| Current Liabilities | $3.13B | -27.7% |
| Long-term Debt | $9.07B | -42.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.03B | -6.1% |
| Capital Expenditures | $908.5M | -34.5% |
| Investing Cash Flow | $684.7M | +137.1% |
| Financing Cash Flow | -$2.25B | -225.0% |
| Free Cash Flow | $1.12B | +44.2% |
| +144.4% |
| Total Liabilities |
| $12.90B |
| -44.1% |
| Stockholders' Equity | $12.37B | -35.1% |